1. Home
  2. CAPR vs HNST Comparison

CAPR vs HNST Comparison

Compare CAPR & HNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Capricor Therapeutics Inc.

CAPR

Capricor Therapeutics Inc.

HOLD

Current Price

$9.37

Market Cap

584.9M

Sector

Health Care

ML Signal

HOLD

Logo The Honest Company Inc.

HNST

The Honest Company Inc.

HOLD

Current Price

$5.99

Market Cap

585.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAPR
HNST
Founded
2005
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Catalog/Specialty Distribution
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
584.9M
585.8M
IPO Year
2011
2021

Fundamental Metrics

Financial Performance
Metric
CAPR
HNST
Price
$9.37
$5.99
Analyst Decision
Strong Buy
Buy
Analyst Count
8
5
Target Price
$44.63
$3.05
AVG Volume (30 Days)
9.1M
3.4M
Earning Date
05-12-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.09
Revenue
N/A
$371,317,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.31
$5.93
P/E Ratio
N/A
$65.22
Revenue Growth
N/A
N/A
52 Week Low
$2.96
$2.07
52 Week High
$40.37
$5.96

Technical Indicators

Market Signals
Indicator
CAPR
HNST
Relative Strength Index (RSI) 49.13 72.78
Support Level $3.66 $3.22
Resistance Level $30.39 N/A
Average True Range (ATR) 1.21 0.27
MACD 0.87 0.02
Stochastic Oscillator 68.14 93.23

Price Performance

Historical Comparison
CAPR
HNST

About CAPR Capricor Therapeutics Inc.

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.

About HNST The Honest Company Inc.

The Honest Co Inc is a personal care company dedicated to creating cleanly-formulated and sustainably-designed products for everyone from babies to adults. By combining thoughtful design with science-based innovation, the company delivers personal care products for everyone from babies to adults, spanning categories across wipes, personal care, diapers, and beauty. It has three product categories namely; Diapers and Wipes, Skin and Personal Care, and Household and Wellness, out of which the majority of its revenue is generated from the sale of diapers and wipes. The company operates only in the United States.

Share on Social Networks: